180 related articles for article (PubMed ID: 6509795)
1. Modulation of macrophage suppressive activity and prostaglandin release by lymphokines and interferon: comparison of alveolar, pleural and peritoneal macrophages.
Sestini P; Tagliabue A; Boraschi D
Clin Exp Immunol; 1984 Dec; 58(3):573-80. PubMed ID: 6509795
[TBL] [Abstract][Full Text] [Related]
2. Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains.
Boraschi D; Pasqualetto E; Ghezzi P; Salmona M; Bartalini M; Barbarulli G; Censini S; Soldateschi D; Tagliabue A
J Immunol; 1983 Oct; 131(4):1707-13. PubMed ID: 6311895
[TBL] [Abstract][Full Text] [Related]
3. Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity.
Boraschi D; Ghezzi P; Pasqualetto E; Salmona M; Nencioni L; Soldateschi D; Villa L; Tagliabue A
Immunology; 1983 Nov; 50(3):359-68. PubMed ID: 6354920
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity.
Boraschi D; Soldateschi D; Tagliabue A
Eur J Immunol; 1982 Apr; 12(4):320-6. PubMed ID: 6178603
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production.
Boraschi D; Censini S; Tagliabue A
J Immunol; 1984 Aug; 133(2):764-8. PubMed ID: 6330202
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma.
Black CM; Catterall JR; Remington JS
J Immunol; 1987 Jan; 138(2):491-5. PubMed ID: 3098846
[TBL] [Abstract][Full Text] [Related]
7. Regulation of macrophage suppression and cytotoxicity by interferon role of Ia-bearing macrophages.
Boraschi D; Niederhuber JE
J Immunol; 1982 Nov; 129(5):1854-8. PubMed ID: 6956630
[TBL] [Abstract][Full Text] [Related]
8. Interferon inhibits prostaglandin biosynthesis in macrophages: effects on arachidonic acid metabolism.
Boraschi D; Censini S; Bartalini M; Scapigliati G; Barbarulli G; Vicenzi E; Donati MB; Tagliabue A
J Immunol; 1984 Apr; 132(4):1987-92. PubMed ID: 6321595
[TBL] [Abstract][Full Text] [Related]
9. IFN-beta-induced reduction of superoxide anion generation by macrophages.
Boraschi D; Ghezzi P; Salmona M; Tagliabue A
Immunology; 1982 Apr; 45(4):621-8. PubMed ID: 6175565
[TBL] [Abstract][Full Text] [Related]
10. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
Boraschi D; Tagliabue A
Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
[TBL] [Abstract][Full Text] [Related]
11. Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma.
Blasi E; Herberman RB; Varesio L
J Immunol; 1984 Jun; 132(6):3226-8. PubMed ID: 6725951
[TBL] [Abstract][Full Text] [Related]
12. Ontogeny of 'macrophage' function. IV. Newborn mouse macrophages strongly suppress tumour cell growth and readily acquire cytolytic activity in comparison with adult macrophages.
Ido M; Uno K; Inaba K; Aotsuka Y; Muramatsu S
Immunology; 1984 Jun; 52(2):307-17. PubMed ID: 6735438
[TBL] [Abstract][Full Text] [Related]
13. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
Davis CE; Belosevic M; Meltzer MS; Nacy CA
J Immunol; 1988 Jul; 141(2):627-35. PubMed ID: 3133412
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of pinocytosis and the production of prostaglandin E2 by hepatic and peritoneal resident macrophages in mice].
Mavier P; Préaux AM; Zafrani ES; Vasconcelos AW; Rosenbaum J; Dhumeaux D
Gastroenterol Clin Biol; 1985; 9(6-7):508-15. PubMed ID: 3860455
[TBL] [Abstract][Full Text] [Related]
15. Relationship between membrane potential changes and superoxide-releasing capacity in resident and activated mouse peritoneal macrophages.
Kitagawa S; Johnston RB
J Immunol; 1985 Nov; 135(5):3417-23. PubMed ID: 2995493
[TBL] [Abstract][Full Text] [Related]
16. Alveolar macrophages. V. Comparative studies on the antigen presentation activity of guinea-pig and rat alveolar macrophages.
Holt PG; Batty JE
Immunology; 1980 Oct; 41(2):361-6. PubMed ID: 6160094
[TBL] [Abstract][Full Text] [Related]
17. Lymphokine maintains macrophage activation for tumor cell killing by interfering with the negative regulatory effect of prostaglandin E2.
Taffet SM; Pace JL; Russell SW
J Immunol; 1981 Jul; 127(1):121-4. PubMed ID: 6263971
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms.
Redmond HP; Shou J; Gallagher HJ; Kelly CJ; Daly JM
J Immunol; 1993 Apr; 150(8 Pt 1):3427-33. PubMed ID: 8385685
[TBL] [Abstract][Full Text] [Related]
19. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
Fernandez-Cruz E; Ulich T; Schreiber RD
J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
[TBL] [Abstract][Full Text] [Related]
20. Correlation of immunogenicity and production of ornithine by peritoneal macrophages.
Kriegbaum H; Benninghoff B; Häcker-Shahin B; Dröge W
J Immunol; 1987 Aug; 139(3):899-904. PubMed ID: 3110288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
